Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

Hypertension

Volumn 35, Issue 2, 2000, Pages 544-549

  He, Jiang ^a   Whelton, Paul K ^a   Appel, Lawrence J ^b   Charleston, Jeanne ^b   Klag, Michael J ^b  

^a TULANE UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Blood pressure; Diet sodium restricted; Hypertension, incidence; Weight loss

Indexed keywords

SODIUM;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SODIUM INTAKE; SODIUM URINE LEVEL; WEIGHT REDUCTION;

EID: 0033982397     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.2.544     Document Type: Article

References (23)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, I: Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335: 765-774.
3. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121:951-957.
4. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
5. Whelton PK, He J, Klag MJ. Blood pressure in Westernized populations. In: Swales JD, ed. Textbook of Hypertension. Oxford, UK: Blackwell Scientific Publications: 1994:11-21.
6. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
7. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578-581.
8. Whelton PK, He J. Prevention trials of blood pressure reduction. In: Hennekens C, Buring J, Furberg C, Manson JE, eds. Clinical Trials in Cardiovascular Disease. Philadelphia, Pa: WB Saunders; 1999.
9. Working Group on Primary Prevention of Hypertension. National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension. Arch Intern Med. 1993;153:186-208.
10. Staessen J, Fagard R, Lijnen P, Amery A. Body weight, sodium intake and blood pressure. J Hypertens. 1989;7:S19-23.
11. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997;81:1077-1097.
12. He J, Whelton PK. What is the role of dietary sodium and potassium in hypertension and target organ injury? Am J Med Sci. 1999;317:152-159.
13. Satterfield S, Cutler JA, Langford HG, Applegate WB, Borhani NO, Brittain E, Cohen JD, Kuller LH, Lasser NL, Oberman A, Rosner B, Taylor JO, Vogt TM, Walker WG, Whelton PK. Trials of hypertension prevention, phase 1 design. Ann Epidemiol. 1991;1:455-471.
14. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention Phase 1. JAMA 267;1992:1213-1220.
15. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial (HPT): 3-year effects of dietary changes in blood pressure. Arch Intern Med. 1990;150:153-162.
16. Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, Phase II. Arch Intern Med. 1997;157:657-667.
17. SAS Institute Inc. SAS/STAT User's guide, version 7-1. Cary, NC: SAS Institute Inc; 1998.
18. Geleijnse JM, Hofman A, Witteman JCM, Hazebroek AAJM, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension. 1997;29:913-917.
19. MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 1987;8(suppl B):57-70.
20. Schotte DE, Stunkard AJ. The effects of weight reduction on blood pressure in 302 obese patients. Arch Intern Med. 1990;150:1701-1704.
21. He J, Whelton PK. Role of sodium reduction in the treatment and prevention of hypertension. Curr Opin Cardiol. 1997;12:202-207.
22. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275:1590-1597.
23. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997;65:643S-651S.